Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.99 USD | +3.95% | +78.37% | +55.34% |
May. 31 | Citigroup Downgrades Calliditas Therapeutics to Neutral From Buy, Price Target at $39 | MT |
May. 31 | Calliditas Partner Secures European Panel Backing for Rare Kidney Disease Treatment | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CALLIDITAS THERAPEUTICS AB | Specialty & Advanced Pharmaceuticals | +3.95% | +78.37% | +55.34% | +128.25% | - | 1.06B | - | - | - |
- Stock Market
- Equities
- CALTX Stock
- CALT Stock
- Charts Calliditas Therapeutics AB
- Relative Strength Chart